Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. / Martin, Diego R; Semelka, Richard C; Chapman, Arlene; Peters, Harm; Finn, Paul J; Kalb, Bobby; Thomsen, Henrik.

In: Journal of Magnetic Resonance Imaging, Vol. 30, No. 6, 2009, p. 1350-6.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Martin, DR, Semelka, RC, Chapman, A, Peters, H, Finn, PJ, Kalb, B & Thomsen, H 2009, 'Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients', Journal of Magnetic Resonance Imaging, vol. 30, no. 6, pp. 1350-6. https://doi.org/10.1002/jmri.21968

APA

Martin, D. R., Semelka, R. C., Chapman, A., Peters, H., Finn, P. J., Kalb, B., & Thomsen, H. (2009). Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. Journal of Magnetic Resonance Imaging, 30(6), 1350-6. https://doi.org/10.1002/jmri.21968

Vancouver

Martin DR, Semelka RC, Chapman A, Peters H, Finn PJ, Kalb B et al. Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. Journal of Magnetic Resonance Imaging. 2009;30(6):1350-6. https://doi.org/10.1002/jmri.21968

Author

Martin, Diego R ; Semelka, Richard C ; Chapman, Arlene ; Peters, Harm ; Finn, Paul J ; Kalb, Bobby ; Thomsen, Henrik. / Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. In: Journal of Magnetic Resonance Imaging. 2009 ; Vol. 30, No. 6. pp. 1350-6.

Bibtex

@article{101c5df085ba11df928f000ea68e967b,
title = "Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients",
abstract = "Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the other cross-sectional imaging modality. Factors to consider include the relative risks of the contrast agent. Other factors include the relative procedural risks, including radiation risks and the relative expected diagnostic yield of the examination technique (12). In this review we describe both nephrogenic systemic fibrosis and contrast-induced nephropathy to compare the implications with regard to relative risks and benefits of contrast-enhanced MRI or CT in patients with impaired renal function. J. Magn. Reson. Imaging 2009;30:1350-1356. (c) 2009 Wiley-Liss, Inc.",
author = "Martin, {Diego R} and Semelka, {Richard C} and Arlene Chapman and Harm Peters and Finn, {Paul J} and Bobby Kalb and Henrik Thomsen",
note = "Keywords: Comorbidity; Contrast Media; Humans; Iodine Compounds; Kidney Failure; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Tomography, X-Ray Computed",
year = "2009",
doi = "10.1002/jmri.21968",
language = "English",
volume = "30",
pages = "1350--6",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "JohnWiley & Sons, Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients

AU - Martin, Diego R

AU - Semelka, Richard C

AU - Chapman, Arlene

AU - Peters, Harm

AU - Finn, Paul J

AU - Kalb, Bobby

AU - Thomsen, Henrik

N1 - Keywords: Comorbidity; Contrast Media; Humans; Iodine Compounds; Kidney Failure; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Tomography, X-Ray Computed

PY - 2009

Y1 - 2009

N2 - Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the other cross-sectional imaging modality. Factors to consider include the relative risks of the contrast agent. Other factors include the relative procedural risks, including radiation risks and the relative expected diagnostic yield of the examination technique (12). In this review we describe both nephrogenic systemic fibrosis and contrast-induced nephropathy to compare the implications with regard to relative risks and benefits of contrast-enhanced MRI or CT in patients with impaired renal function. J. Magn. Reson. Imaging 2009;30:1350-1356. (c) 2009 Wiley-Liss, Inc.

AB - Magnetic resonance imaging (MRI) and computed tomography (CT) have become essential to diagnostic evaluation of many, or most, important medically and surgically treated diseases. It is important to consider comprehensively the implications in making decisions when choosing one or the other cross-sectional imaging modality. Factors to consider include the relative risks of the contrast agent. Other factors include the relative procedural risks, including radiation risks and the relative expected diagnostic yield of the examination technique (12). In this review we describe both nephrogenic systemic fibrosis and contrast-induced nephropathy to compare the implications with regard to relative risks and benefits of contrast-enhanced MRI or CT in patients with impaired renal function. J. Magn. Reson. Imaging 2009;30:1350-1356. (c) 2009 Wiley-Liss, Inc.

U2 - 10.1002/jmri.21968

DO - 10.1002/jmri.21968

M3 - Journal article

C2 - 19937934

VL - 30

SP - 1350

EP - 1356

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 6

ER -

ID: 20621378